Results 141 to 150 of about 4,051 (205)

Clinical effect of bisphosphonate in patients with hormone receptor-positive early breast cancer: A nationwide real-world data analysis. [PDF]

Breast
Choi W, Kang M, Lee K, Park IH.
europepmc   +1 more source

No Significant Improvement in Osteoporosis Management of Post-fragility Fracture Patients From 2010 to 2019: A National Database Study. [PDF]

J Am Acad Orthop Surg Glob Res Rev
Smith HD, Smith S, Turner N, Friess D, Working Z, DeKeyser G, Yoo J.   +6 more
europepmc   +1 more source

Comparative efficacy and safety of odanacatib, abaloparatide, denosumab, teriparatide, and bisphosphonates for male osteoporosis: a systematic review and network meta-analysis. [PDF]

Front Endocrinol (Lausanne)
Lu C, Zhang L, Xue C, Liao M, Fei J, Chen X, Wang L.   +6 more
europepmc   +1 more source

Polyphosphonate covalent organic frameworks. [PDF]

Nat Commun
Xu K, Oestreich R, Haj Hassani Sohi T, Lounasvuori M, Ruthes JGA, Zorlu Y, Michalski J, Seiffert P, Strothmann T, Tholen P, Ozgur Yazaydin A, Suta M, Presser V, Petit T, Janiak C, Beckmann J, Schmedt Auf der Günne J, Yücesan G.   +17 more
europepmc   +1 more source

Bisphosphonate alternative regimens for the prevention of osteoporotic fragility fractures: BLAST-OFF, a mixed-methods study.

Health Technol Assess
Sahota O, Narayanasamy M, Bastounis A, Paskins Z, Bishop S, Langley T, Gittoes N, Davis S, Baily A, Holmes M, Leonardi-Bee J.   +10 more
europepmc   +1 more source

Effects of Osteoporosis Medication Use on Reprocedure Rates Following Vertebral Augmentation: A Nationwide Cohort Study. [PDF]

Clin Orthop Surg
Park SR, Lee BH, Suk KS, Kim N, Park M, Park SY, Moon SH, Kim HS, Shin JW, Kwon JW.   +9 more
europepmc   +1 more source

Follow-on osteoporosis therapy after denosumab discontinuation among Medicare beneficiaries. [PDF]

Osteoporos Int
Sendhil SR, Cadarette SM, Aggarwal S, Oganisian A, Zullo AR, Berry SD, Adegboye MA, Hayes KN.   +7 more
europepmc   +1 more source

Histological and morphometrical evaluation of non-critical bone defects after treatment with biomaterial and bisphosphonates. [PDF]

Med Oral Patol Oral Cir Bucal
Fernandes GV, Martins BG, Heboyan A, Castilho RM, Fernandes JC.   +4 more
europepmc   +1 more source

A disproportionality analysis of cardiac arrhythmia associated with bisphosphonates based on the FAERS database. [PDF]

Sci Rep
Wang F, Xu G, Wang Q, Wu X.
europepmc   +1 more source